These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12773446)

  • 1. An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI.
    Platteau P; Laurent E; Albano C; Osmanagaoglu K; Vernaeve V; Tournaye H; Camus M; Van Steirteghem A; Devroey P
    Hum Reprod; 2003 Jun; 18(6):1200-4. PubMed ID: 12773446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the efficacy, tolerability, and convenience of two formulations of follitropin-alpha in Iranian woman undergoing intracytoplasmic sperm injection cycles.
    Aghssa MM; Azargoon A; Ramezanzadeh F; Bagheri M
    Fertil Steril; 2008 Oct; 90(4):1043-8. PubMed ID: 18053995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of follitropin-beta administered by a pen device with conventional syringe in an ART programme - a retrospective study.
    Rama Raju GA; Suryanarayana K; Jaya Prakash G; Murali Krishna K
    J Clin Pharm Ther; 2008 Aug; 33(4):401-7. PubMed ID: 18613858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of follitropin β administered by a pen device with follitropin β administered by a conventional syringe in patients undergoing IVF-ET.
    Kang HJ; Kim CH; Ahn JW; Lee HA; Kim SH; Chae HD; Kang BM
    Clin Exp Reprod Med; 2011 Mar; 38(1):37-41. PubMed ID: 22384416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.
    Kolibianakis EM; Venetis CA; Bosdou JK; Zepiridis L; Chatzimeletiou K; Makedos A; Masouridou S; Triantafillidis S; Mitsoli A; Tarlatzis BC
    Hum Reprod; 2015 Feb; 30(2):432-40. PubMed ID: 25492411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical application of prefilled pen and conventional syringe during controlled ovarian stimulation for in vitro fertilization].
    Chen LN; Quan S; Li H; Yang XP; Chen SM; Zhang XY; Lin L; Xing FQ; Chen SL; Wan ZJ; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):100-4. PubMed ID: 19218125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a pen device for self-administration of recombinant human FSH in clomiphene citrate-resistant anovulatory women undergoing ovulation induction.
    Kettel LM; Scholl G; Bonaventura L; Pang S; Sacks P; Chantilis S; Mahony M;
    Reprod Biomed Online; 2004 Oct; 9(4):373-80. PubMed ID: 15511333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a fully automated injector for self-administration of follitropin alpha in an IVF/ICSI programme.
    Greco E; Polonio-Balbi P; Ferrero S; Baroni E; Ubaldi F; Rienzi L; Tesarik J
    Reprod Biomed Online; 2005 Oct; 11(4):415-20. PubMed ID: 16274597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study.
    Welcker JT; Nawroth F; Bilger W
    Reprod Biol Endocrinol; 2010 Sep; 8():111. PubMed ID: 20843323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of recombinant human FSH (solution in cartridge) with a pen device in women undergoing ovarian stimulation.
    Pang S; Kaplan B; Karande V; Westphal LM; Scott R; Givens C; Sacks P;
    Reprod Biomed Online; 2003 Oct; 7(3):319-26. PubMed ID: 14653893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follitropin-beta administered by pen device has superior local tolerance compared with follitropin-alpha administered by conventional syringe.
    Craenmehr E; Bontje PM; Hoomans E; Voortman G; Mannaerts BM
    Reprod Biomed Online; 2001; 3(3):185-189. PubMed ID: 12513852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and nurse evaluation of recombinant human follicle-stimulating hormone administration methods: comparison of two follitropin injection pens.
    Porter R; Kissel C; Saunders H; Keck C
    Curr Med Res Opin; 2008 Mar; 24(3):727-35. PubMed ID: 18230195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of the administration of follitropin-beta with a pen device.
    Bruynesteyn K; Bonsel GJ; Braat DD; Fauser BC; Devroey P; van Genugten ML
    Reprod Biomed Online; 2005 Jul; 11(1):26-35. PubMed ID: 16102283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy and tolerability of two recombinant human follicle-stimulating hormone preparations in patients undergoing in vitro fertilization-embryo transfer.
    Brinsden P; Akagbosu F; Gibbons LM; Lancaster S; Gourdon D; Engrand P; Loumaye E
    Fertil Steril; 2000 Jan; 73(1):114-6. PubMed ID: 10632423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women.
    Somkuti SG; Schertz JC; Moore M; Ferrande L; Kelly E;
    Curr Med Res Opin; 2006 Oct; 22(10):1981-96. PubMed ID: 17022858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial.
    Nyboe Andersen A; Nelson SM; Fauser BC; García-Velasco JA; Klein BM; Arce JC;
    Fertil Steril; 2017 Feb; 107(2):387-396.e4. PubMed ID: 27912901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF/ICSI cycles.
    Yu S; Long H; Chang HY; Liu Y; Gao H; Zhu J; Quan X; Lyu Q; Kuang Y; Ai A
    Hum Reprod; 2018 Feb; 33(2):229-237. PubMed ID: 29300975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly purified human-derived follicle-stimulating hormone (Bravelle) has equivalent efficacy to follitropin-beta (Follistim) in infertile women undergoing in vitro fertilization.
    Dickey RP; Nichols JE; Steinkampf MP; Gocial B; Thornton M; Webster BW; Bello SM; Crain J; Marshall DC;
    Reprod Biol Endocrinol; 2003 Oct; 1():63. PubMed ID: 14609434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.